Hepion Pharmaceuticals, Inc. (HEPA)
Hepion Pharmaceuticals, Inc., a U.S.-based biopharmaceutical entity, is dedicated to developing therapeutic interventions for chronic hepatic ailments. Central to their efforts is Rencofilstat, a cyclophilin inhibitor that has successfully concluded Phase 2a clinical trials. This compound operates by disrupting multiple pathological pathways implicated in the worsening of liver disease. It is currently progressing through clinical development for non-alcoholic steatohepatitis (NASH) and is additionally being explored in nonclinical research for its potential to reduce liver fibrosis and lessen hepatocellular carcinoma tumor loads in experimental models of NASH. Moreover, Rencofilstat has exhibited antiviral properties against hepatitis B, C, and D viruses through diverse mechanisms. The company, established in 2013 and situated in Edison, New Jersey, rebranded as Hepion Pharmaceuticals, Inc. in July 2019, having previously operated as ContraVir Pharmaceuticals, Inc.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Hepion Pharmaceuticals, Inc.
OTC:HEPAHealthcare · Biotechnology
-6.29%$0.1312
Mkt Cap$11.84M
Float20.97M
O/S90.22M
Inst Own0.0%
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$0
Net Income-$8.28M
Total Assets$3.07M
Free Cash Flow-$3.27M
Debt & Equity
Debt 1%
Equity 60%
Preferred 38%
Total Debt$54K
Total Equity$2.67M
Preferred Stock$1.7M
Shares Outstanding
Short Interest
Split History4 splits · 4 reverse
2-year cumulative
1:50
Nasdaq bars a compliance period at 1:250
- 1:50Reverse splitMar 18, 202550 shares → 1
- 1:20Reverse splitMay 11, 202320 shares → 1
- 1:70Reverse splitJun 3, 201970 shares → 1
- 1:8Reverse splitMay 29, 20188 shares → 1
Balance Sheet Details
Assets$3.07M
Liabilities$402K
Accounts Receivable$0
Accounts Payable$168K
Inventory$0
PP&E (Net)$0
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2017-06-30 | 2016-06-30 | 2015-06-30 | 2014-06-30 | 2013-06-30 |
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $27K | $19K | $22K | $0 | $22K | $16K | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 | $0 | $0 | -$27K | -$19K | -$22K | $0 | -$22K | -$16K | $0 | $0 |
| Gross Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Research and Development | $446K | $11.85M | $35.64M | $33.27M | $20.4M | $12M | $3.18M | $7.59M | $14.33M | $13.65M | $15.02M | $8.4M | $314K | $735K |
| Selling, General, and Administrative | $3.32M | $7.5M | $9.62M | $10.35M | $10.01M | $8.15M | $4.59M | $7M | $6.69M | $7.37M | $5.79M | $5.56M | $1.36M | $106K |
| Other | $403K | $0 | $3.19M | $1.87M | $0 | $0 | $0 | -$109K | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $4.16M | $19.35M | $48.45M | $45.49M | $30.4M | $20.15M | $7.77M | $14.59M | $21.02M | $21.02M | $20.81M | $13.96M | $1.67M | $841K |
| Operating Income (EBIT) | -$4.16M | -$19.35M | -$48.45M | -$45.49M | -$30.4M | -$20.15M | -$7.77M | -$14.59M | -$21.04M | -$21.02M | -$20.81M | -$13.96M | -$1.67M | -$841K |
| Operating Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Expense | $24K | $1.25M | $9K | $10K | $9K | $31K | $555K | $339K | $0 | $0 | $0 | $0 | $0 | $0 |
| Interest Income | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Income (Expense) | -$4.11M | $3.18M | -$887K | $405K | -$2.32M | -$177K | -$176K | $4.61M | $2.13M | $4.22M | $3.81M | -$388K | -$3.61M | -$2K |
| Income Before Tax (EBT) | -$8.28M | -$16.16M | -$49.34M | -$45.08M | -$32.72M | -$20.32M | -$7.95M | -$9.99M | -$18.92M | -$16.8M | -$17M | -$14.35M | -$5.28M | -$843K |
| Income Tax Expense | $0 | -$2.97M | -$409K | -$2.88M | $0 | $31K | -$909K | -$536K | -$3.9M | -$1.91M | $0 | $0 | $0 | -$2K |
| Net Income | -$8.28M | -$13.19M | -$48.93M | -$42.2M | -$32.72M | -$20.35M | -$7.04M | -$9.45M | -$15.02M | -$14.89M | -$17M | -$14.35M | -$5.28M | -$843K |
| Net Income Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Supplementary Data | ||||||||||||||
| EPS | -0.88 | -107.35 | -616.07 | -594.75 | -465.52 | -2103.70 | -6108.07 | -97353.00 | -106400.00 | -2855.94 | -352800.00 | -571200.00 | -229600.00 | -11200.00 |
| Diluted EPS | -0.88 | -107.35 | -616.07 | -594.75 | -465.52 | -2103.70 | -6108.07 | -97353.00 | -106400.00 | -3373.93 | -352800.00 | -571200.00 | -229600.00 | -11200.00 |
| Weighted Average OS | 9.41M | 122,894 | 79,416 | 76,229 | 70,291 | 9,677 | 2,043 | 184 | 138 | 5,204 | 48 | 39 | 23 | 16 |
| EBITDA | -$3.73M | -$14.88M | -$49.26M | -$45M | -$32.63M | -$20.11M | -$7.74M | -$14.58M | -$20.62M | -$21.02M | -$20.81M | -$13.94M | -$1.67M | -$2 |
| EBITDA Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2017-06-30 | 2016-06-30 | 2015-06-30 | 2014-06-30 | 2013-06-30 |
| Assets | ||||||||||||||
| Current Assets | ||||||||||||||
| Cash and Cash Equivalents | $1.83M | $406K | $14.79M | $51.19M | $91.35M | $40.73M | $13.92M | $2.83M | $5.95M | $12.98M | $7.4M | $4.56M | $1.82M | $87K |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $1.83M | $406K | $14.79M | $51.19M | $91.35M | $40.73M | $13.92M | $2.83M | $5.95M | $12.98M | $7.4M | $4.56M | $1.82M | $87K |
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $0 | $0 | $0 | $0 | -$0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Current Assets | $3.07M | $1.61M | $17.49M | $56.5M | $97.45M | $42.63M | $14.39M | $2.97M | $6.06M | $13.19M | $7.89M | $5.24M | $1.98M | $87K |
| Long-Term Assets | ||||||||||||||
| Property, Plant & Equipment Net | $0 | -$1 | $242K | $3.32M | $456K | $665K | $855K | $32K | $57K | $68K | $81K | $81K | $15K | $0 |
| Goodwill | $0 | $0 | $0 | $0 | $1.87M | $1.87M | $1.87M | $1.87M | $1.87M | $1.87M | $1.87M | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $3.19M | $3.19M | $3.19M | $3.19M | $3.19M | $0 | $3.19M | $3.19M | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | -$731K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $731K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $0 | $1 | $364K | -$2.76M | $583K | $285K | $307K | $128K | $3.26M | $63K | $70K | $51K | $4K | $0 |
| Total Long-Term Assets | $0 | $0 | $607K | $3.75M | $6.1M | $6.01M | $6.22M | $5.22M | $5.19M | $5.19M | $5.21M | $133K | $19K | $0 |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $3.07M | $1.61M | $18.09M | $60.24M | $103.55M | $48.65M | $20.61M | $8.19M | $11.25M | $18.38M | $13.11M | $5.38M | $2M | $87K |
| Liabilities | ||||||||||||||
| Current Liabilities | ||||||||||||||
| Accounts Payable | $168K | $220K | $2.35M | $2.67M | $2.45M | $3.72M | $492K | $748K | $1.56M | $1.63M | $4.25M | $1.48M | $244K | $4K |
| Short-Term Debt | $54K | $2.9M | $0 | $0 | $0 | $0 | $0 | $1.44M | $0 | $0 | $0 | $0 | $0 | $100K |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $37K | $432K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$100K |
| Other Current Liabilities | $0 | $0 | $386K | $2.27M | $2.99M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $7K | $0 |
| Total Current Liabilities | $299K | $3.14M | $5.29M | $7.89M | $8.21M | $4.66M | $1.61M | $2.85M | $2.6M | $2.94M | $5.08M | $1.94M | $459K | $227K |
| Long-Term Liabilities | ||||||||||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $177K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $409K | $0 | $409K | $409K | $361K | $897K | $1.27M | $1.27M | $0 | $0 | $0 |
| Other Long-Term Liabilities | $103K | $333K | $5.43M | $2.09M | $2.3M | $2.58M | $2.44M | $3M | $4.05M | $5.11M | $5.44M | $0 | $4.48M | $0 |
| Total Long-Term Liabilities | $103K | $333K | $5.52M | $2.5M | $2.35M | $3.46M | $3.39M | $3.36M | $4.95M | $6.38M | $6.71M | $0 | $4.48M | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $402K | $3.48M | $10.81M | $10.39M | $10.56M | $8.12M | $4.99M | $6.21M | $7.55M | $9.33M | $11.79M | $1.94M | $4.93M | $227K |
| Stockholders' Equity | ||||||||||||||
| Preferred Stock | $1.7M | $1.7M | $1.7M | $1.7M | $1.7M | $1.71M | $1.72M | $1.79M | $1.04M | $1.04M | $13.7M | $13.7M | $1 | $0 |
| Common Stock | $1K | $14 | $482 | $381 | $8K | $3K | $375 | $25 | $8K | $8K | $3K | $2K | $2K | $900 |
| Retained Earnings | -$246.1M | -$237.82M | -$224.63M | -$175.7M | -$133.5M | -$104.11M | -$83.75M | -$76.46M | -$67.01M | -$59.5M | -$44.61M | -$27.61M | -$5.42M | -$140K |
| Comprehensive Income & Other | $8K | $8K | -$79K | -$90K | $0 | -$0 | $0 | $0 | -$0 | $0 | $0 | $0 | $0 | -$900 |
| Other Stockholders' Equity | $248.76M | $235.96M | $231.91M | $225.56M | $226.49M | $144.62M | $99.37M | $78.44M | $70.71M | $68.55M | $45.93M | $31.05M | $2.49M | -$900 |
| Total Equity | $2.67M | -$1.86M | $7.28M | $49.86M | $93M | $40.52M | $15.62M | $1.98M | $3.7M | $9.06M | $1.32M | $3.44M | -$2.93M | -$140K |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $3.07M | $1.61M | $18.09M | $60.24M | $103.55M | $48.65M | $20.61M | $8.19M | $11.25M | $18.38M | $13.11M | $5.38M | $2M | $87K |
| Supplementary Data | ||||||||||||||
| Total Debt | $54K | $2.9M | $209K | $54K | $317K | $752K | $807K | $1.44M | $0 | $0 | $10K | $0 | $0 | $100K |
| Net Debt | -$1.77M | $2.49M | -$14.58M | -$51.14M | -$91.03M | -$39.97M | -$13.12M | -$1.39M | -$5.95M | -$12.98M | -$7.39M | -$4.56M | -$1.82M | $14K |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2017-06-30 | 2016-06-30 | 2015-06-30 | 2014-06-30 | 2013-06-30 |
| Operating Activities | ||||||||||||||
| Net Income | -$8.28M | -$13.19M | -$48.93M | -$42.2M | -$32.72M | -$20.35M | -$7.04M | -$9.45M | -$15.02M | -$14.89M | -$17M | -$14.35M | -$5.28M | -$843 |
| Depreciation & Amortization | $31K | $31K | $67K | $77K | $86K | $35K | $27K | $19K | $22K | $28K | $22K | $16K | $1K | $841K |
| Deferred Income Tax | $0 | $0 | -$409K | $0 | $0 | $0 | $48K | -$536K | -$373K | -$4.22M | $0 | $388K | $0 | $0 |
| Stock-Based Compensation | $21K | $792K | $1.34M | $2.55M | $4.67M | $2.38M | $66K | $235K | $2K | $1.7M | $902K | $2.12M | $195K | $0 |
| Changes in Working Capital: | ||||||||||||||
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | $0 | $0 | $0 | $0 | -$1.07M | $0 | -$317K | -$898K | -$111K | $0 | $0 | $0 | $0 | $0 |
| Other Working Capital | $493K | -$2.68M | $2.97M | $3.15M | -$4.5M | $1.63M | -$509K | -$970K | $92K | $0 | $3.33M | $953K | -$169 | $0 |
| Total Working Capital Change | $493K | -$2.68M | $2.97M | $3.15M | -$5.57M | $1.63M | -$826K | -$970K | -$19K | -$1.84M | $3.33M | $953K | $125K | $0 |
| Other Non-Cash Items | $4.46M | -$3.16M | $4.07M | $1.46M | $2.31M | $146K | $157K | -$4.94M | $7.34M | -$4.17M | -$3.81M | $1.59M | $3.6M | -$840K |
| Net Cash from Operating | -$3.27M | -$18.22M | -$40.89M | -$34.96M | -$31.22M | -$16.17M | -$7.57M | -$15.65M | -$8.21M | -$19.17M | -$16.56M | -$9.67M | -$1.36M | -$80 |
| Investing Activities | ||||||||||||||
| Capital Expenditures | $0 | $0 | -$14K | -$16K | -$130K | -$88K | -$51K | $0 | -$2 | -$15K | -$7K | -$83K | -$16K | $0 |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $900 | $0 | $0 | -$496K | $0 | $0 | $0 |
| Purchases of Investments | -$132K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | -$600K | $0 | $2K | $0 | $2K | $0 | $1 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Cash from Investing | -$132K | -$600K | -$14K | -$14K | -$130K | -$86K | -$51K | $900 | -$2 | -$15K | -$502K | -$83K | -$16K | $0 |
| Financing Activities | ||||||||||||||
| Debt Repaid | $3.37M | - | - | - | $177K | -$177K | $1.12M | - | - | $10K | - | - | $100K | - |
| Common Stock Issuance | $9M | $2.5M | $0 | $0 | $82.15M | $42.87M | $7.68M | $1.64M | $1.18M | $24.66M | $19.9M | $12.5M | $3.23M | $0 |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | -$803K | $1.85M | $4.49M | -$2M | $0 | $12K | $2.09M | -$857K | $11.9M | $116K | $19.9M | $1K | -$15K | $600 |
| Net Cash from Financing | $4.83M | $4.35M | $4.49M | -$5.14M | $81.98M | $43.05M | $18.71M | $12.52M | $1.18M | $24.77M | $19.9M | $12.5M | $3.11M | $600 |
| Forex Effect | $0 | $87K | $5K | -$47K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $1.42M | -$14.38M | -$36.4M | -$40.16M | $50.62M | $26.8M | $11.09M | -$3.12M | -$1.45M | $5.58M | $2.84M | $2.75M | $1.73M | $520 |
| Supplementary Data | ||||||||||||||
| Operating Cash Flow | -$3.27M | -$18.22M | -$40.89M | -$34.96M | -$31.22M | -$16.17M | -$7.57M | -$15.65M | -$8.21M | -$19.17M | -$16.56M | -$9.67M | -$1.36M | -$80 |
| Capital Expenditure | $0 | $0 | -$14K | -$16K | -$130K | -$88K | -$51K | $0 | -$2 | -$15K | -$7K | -$83K | -$16K | $0 |
| Free Cash Flow | -$3.27M | -$18.22M | -$40.9M | -$34.98M | -$31.35M | -$16.25M | -$7.62M | -$15.65M | -$8.21M | -$19.19M | -$16.56M | -$9.76M | -$1.38M | -$80 |
| Cash at Beginning | $406K | $14.79M | $51.19M | $91.35M | $40.73M | $13.92M | $2.83M | $5.95M | $7.4M | $7.4M | $4.56M | $1.82M | $87K | $0 |
| Cash at End | $1.83M | $406K | $14.79M | $51.19M | $91.35M | $40.73M | $13.92M | $2.83M | $5.95M | $12.98M | $7.4M | $4.56M | $1.82M | $520 |